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564consequences of right ventricular
dilation, mainly sudden death and
requirement of a pulmonary valve
implantation (7).
It is yet unknown whether the
transatrial approach, by mini-
mizing the incision to the right
ventricular wall, may offer betterlate outcomes after Fallot repair. In the early 1980s, our team
adopted the transatrial approach as its sole technique to
repair tetralogy of Fallot (4). Over the course of 25 years, our
team maintained a policy of early shunting of patients before
the age of 4 months if they were suffering from deep
cyanosis, cyanotic spells, or if their pulmonary arteries were
too small to permit repair. We retrospectively reviewed the
late outcomes of this policy and this surgical technique in the
patients operated in our institution.
Methods
The design of the study was approved by the local research
ethics committee of the Royal Children’s Hospital, and the
need for individual patient consent was waived because of
the retrospective nature of the research.
Patients. In the Royal Children’s Hospital, Melbourne,
Australia, the ﬁrst transatrial repair of tetralogy of Fallot was
performed in 1980. During 1980 and 1981, 35 patients
underwent a transventricular repair and 27 a transatrial
repair. Thereafter, transatrial repair was the only technique
used in our center. The records of all Australian patients
undergoing a transatrial repair of tetralogy of Fallot in our
hospital from 1980 to 2005 were reviewed. Patients with
absent or atretic pulmonary valve, atrioventricular septal
defects, and double outlet right ventricles were excluded.
There were 675 consecutive patients who constituted the
study group (420 males). A total of 220 (33%) patients had
undergone the following previous palliative procedures
before repair at a mean age of 402  206 days: Blalock-
Taussig shunt (n ¼ 196), central shunt (n ¼ 10), bilateral
shunts (n ¼ 3), Waterston shunt (n ¼ 10), and balloon
dilation of the RVOT (n ¼ 1). The median age at repair was
2.0 years of age from 1980 to 1987, and then remained
steady at 1.0 years of age from 1988 onward.
Patient cohort to study the strategy of palliation at an early
age of cyanotic patients and later transatrial repair. In
order to identify survival from birth, we analyzed the
subgroup of 628 patients recorded in our hospital database
to have tetralogy of Fallot and born after 1981, when
transatrial repair had become the sole technique used in our
center.
Follow-up studies. To study freedom from reoperation
and survival following transatrial repair, 8 patients who
underwent implantation of a valved conduit between the
right ventricle and the pulmonary artery at the time of the
repair were excluded limiting the study cohort to 667
patients for this analysis. Follow-up data were gatheredfrom the hospital databases of all pediatric and adult
departments caring for congenital heart disease in
Victoria, South Australia, and Western Australia and
from information gathered by their referring cardiologists or
their regular physician during the years 2003 to 2009. The
survival status of patients who had no concurrent cardiology
or other clinic attendance was ascertained by contacting
patients or their families by telephone and by checking the
Australian Electoral Roll and records held by registries of
births, deaths, and marriages, and their survival status was
therefore assumed to be completed at the time of this
investigation. Seven interstate patients could not be accoun-
ted for in any registry.
Surgical techniques. All procedures were performed under
mild hypothermia. All ventricular septal defects were closed
via a right atriotomy through the tricuspid valve oriﬁce. The
RVOT obstruction was resected through the right atriotomy
and a longitudinal incision of the pulmonary artery. Details
of the opening of the outﬂow tract were available in 577 of
the 675 patients. The pulmonary incision was considered to
be transannular because it extended through the hinge points
of the pulmonary leaﬂets and up to a few millimeters on the
pulmonary infundibulum in 433 patients (75%). Autologous
pericardium was the material used to patch this incision in
92% of cases. The rate of transannular patching did not vary
over time (1980 to 1989: 68%; 1990 to 1999: 79%; 2000 to
2005: 76%). In the early part of the study, these pericardial
patches were untreated and in the late 1990s, treatment of
pericardial patches with glutaraldehyde was initiated, so that
83% of the patches used in this series were untreated. The
need for transannular incision was left to the individual
surgeon preferences and post-operative measurements of
right ventricular pressures were not routinely performed.
Atrial septal defects and patent foramen ovale were routinely
closed in all patients. The origin of the right and/or the left
pulmonary arteries were felt to be too restrictive in 123
patients and were enlarged with a patch of autologous
pericardium. The vessels enlarged were the left pulmonary
artery (n ¼ 82), the right pulmonary artery (n ¼ 19), or both
(n ¼ 22). Pulmonary valve replacement during follow-up was
usually undertaken when there was severe pulmonary regur-
gitation in the presence of right ventricular dilation, right
ventricular dysfunction, or symptoms suggestive of progres-
sive exercise intolerance. Only in recent times, magnetic
resonance imagingmeasurements of right ventricular volumes
superior to 170ml/m2 became an absolute indication for valve
replacement surgery. Smaller volumes were subjected to
consensus decision. Amean outﬂow tract gradient superior to
50 mm Hg constituted an indication for surgery to relieve
right ventricular outﬂow obstruction.
Statistical analysis. All values are given in mean  SD and
median (interquartile range) where appropriate. Kaplan-
Meier analysis was used to estimate survival from birth and
survival and freedom from reoperation following transatrial
repair. Patients exited a model in the event of death or
occurrence of reoperation for survival and reoperation,
Figure 1 Transventricular and Transatrial Repair
Diagram of the 2 main techniques of Fallot repair. In the transventricular repair (left), the ventricular septal defect (VSD) is closed through the ventriculotomy. In the transatrial
repair (right), the VSD is closed through a right atriotomy, through the tricuspid valve. It is claimed that in transatrial repair the length of incision of the right ventricular outﬂow
tract is smaller than in the transventricular repair.
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indication (right ventricular dilation, right ventricular
outﬂow obstruction, or pulmonary artery stenosis), patients
were retained in the model if a reoperation for another
indication occurred. Risk factors for reoperation were
analyzed using Cox proportional hazards regression. The
factors examined were: sex, prior palliation, age at repair,
transannular incision, nature of the patch, patching of
pulmonary artery origin, addition of a monocusp valve, and
post-operative echocardiographic gradient (Online Tables
1a and 1b). Initially, factors were assessed on a univariate
basis. Factors with hazard ratios (HRs) indicating a 50%
increase or corresponding decrease in risk and with a p value
below 10% were included in a multivariable model.Results
Survival from birth after a strategy of early palliation of
cyanotic patients and later transatrial repair. Survival
from birth of the cohort of 628 patients born after 1981 is
displayed in Figure 2. One patient died before any surgery
was offered. Two hundred and three patients (32.4%)
required the creation of a palliative procedure to increase
pulmonary blood ﬂow before repair at a median age of 3
months (1.1 to 5.4 months). Two patients died in hospital
after this initial palliative surgery and 5 between the shunt
surgery and the ﬁnal repair. There were 7 hospital deaths.
Eight late deaths occurred after hospital discharge, and the
causes of death were sudden unexpected death (n ¼ 2),
pneumonia (n ¼ 2), post-operative complications after renal
transplantation (n ¼ 1) or arch repair (n ¼ 1), the lateconsequences of a perioperative stroke (n ¼ 1), and
unknown (n ¼ 1). The survival from birth to age 1, 3, and
25 years for these babies born with tetralogy of Fallot was
98.8% (95% conﬁdence interval [CI]: 97.7% to 99.4%),
97.0% (95% CI: 95.5% to 98.2%), and 95.7% (95% CI:
93.1% to 97.3%), respectively.
Survival after transatrial repair. A total of 675 patients
underwent a transatrial repair in the 25 years between 1980
and 2005. The 7 patients who died during hospital stay
accounted for a hospital mortality of 1%. The 25-year
survival from transatrial repair of this population was
96.9% (95% CI: 94.9% to 98.2%).
Reoperations. A total of 54 interventional catheterization
procedures were performed in 38 of the 651 survivors of the
procedure on the left pulmonary artery (n ¼ 32), the right
pulmonary artery (n ¼ 17), the pulmonary artery bifurcation
(n ¼ 10), or the RVOT (n ¼ 4).
There were 115 patients who required 135 reoperations
consisting in implantation of a valved conduit between the
right ventricle and the main pulmonary artery (n ¼ 22),
relief of RVOT obstruction (n ¼ 56), patching of the
pulmonary artery origin (n ¼ 20), closure of a residual
ventricular septal defect (n ¼ 10), tricuspid valve repair (n ¼
8), pacemaker implantation (n ¼ 9), and others (10). The
freedom from implantation of a valved conduit at 5, 10, 15,
and 25 years was 99.0% (95% CI: 97.8% to 99.6%), 97.6%
(95% CI: 95.8% to 98.6%), 91.7% (95% CI: 88.0% to
94.3%), and 84.6% (95% CI: 77.8% to 89.5%), respectively.
By multivariable analysis, prior palliation and younger age at
repair were predictive of implantation of a valved conduit
(HR: 2.4, 95% CI: 1.3 to 4.6, p ¼ 0.008; HR: 0.70, 95% CI:
Figure 2
Survival From Birth in a Strategy of Early Shunting of
Cyanosed Patients and Later Transatrial Repair
(n ¼ 628; Palliation in 32% of Patients)
For the last 3 decades the patients born with tetralogy of Fallot operated in the
Royal Children’s Hospital, Melbourne, Australia, were entered in a strategy of
repair beyond the neonatal age. All patients presenting in the ﬁrst months of life
with cyanosis, spells, or small pulmonary arteries were palliated with shunts.
Shunts were performed in 203 of the 628 consecutive patients entered in this
strategy resulting in a 25-year survival rate of 96%.
Figure 3
Freedom From Implantation of a Valved Conduit in the
Right Ventricular Outﬂow Tract According to Whether
Patient Had Palliative Surgery Prior to Fallot Repair
In this strategy of transatrial repair beyond the neonatal period, the patients who
had previous palliation were at higher risk of requiring the implantation of a valved
conduit in their right ventricular outﬂow tract for progressive right ventricular dila-
tion (hazard ratio: 2.4; 95% conﬁdence interval: 1.3 to 4.6; p ¼ 0.008).
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implantation of a valved conduit according to prior palliation
and age at Fallot repair are illustrated in Figures 3 and 4.
The ﬁrst reinterventions were classiﬁed following their
main indication into indication for right ventricular dilation
(n ¼ 36), RVOT obstruction (n ¼ 53), or pulmonary artery
origin stenosis (n ¼ 21). Twenty-ﬁve years’ freedom from
reoperation for right ventricular dilation, residual RVOT
obstruction, or pulmonary artery stenosis, or all 3 of them,
were 86.5% (95% CI: 80% to 91%), 89% (95% CI: 85.5% to
92%), 95.5% (95% CI: 92.5% to 97.5%), and 75% (95% CI:
70% to 80%), respectively (Fig. 5). Risks factors predicting
reoperations on the RVOT or the pulmonary arteries are
displayed in Table 1.
Functional status and echocardiographic results. After
a mean follow-up of 12 6 years, 465 patients were evaluated
to be in New York Heart Association functional class I (92%),
and 42 patients in class II (8%).
Echocardiographic data could be obtained in 496 of
the survivors. Severity of pulmonary regurgitation was re-
ported in 375 patients and was estimated to be severe in
193 patients (51%), moderate in 96 (26%), and mild in 86
(23%). Their mean peak gradient through the RVOT was
28.8  18.9 mm Hg. Only 29 patients were evaluated to
have gradient superior to 30 mm Hg. Additionally, 2
patients had more than mild aortic valve regurgitation. The
left ventricular function was normal in all but 35 patients.
Right ventricular size was subjectively estimated to be mildly
dilated in 176, moderately dilated in 82, and severely dilated
in 14 patients.Discussion
In the last decades, tetralogy of Fallot has been repaired with
a minimal mortality and our focus should turn now to offer
the best late functional outcomes to these patients repaired
in infancy. The major complication facing these patients is
related to the progressive dilation of their right ventricle
because of the long-standing pulmonary regurgitation
caused by the opening of their narrow RVOT. The most
severe complication of this dilation is sudden death due to
ventricular arrhythmia (5–10). It is likely that a better
understanding of this lethal complication and improved
follow-up of our patients has resulted in a reduction of this
feared complication. Only 2 of our patients suffered a sudden
death and we do not believe to have missed information
because we checked our national death registries. The most
common complication related to right ventricular dilation is
the need to implant a valved conduit in the RVOT. After an
initial valve implantation procedure, the patients will require
repetitive intervention to replace these conduits. There is
a scarcity of data predicting the need for valve implantation in
patients who have been operated in the recent times and our
perception of this risk is based only on historical series. From
existing data, a reasonable estimate of this risk of reoperation
at 20 years would be 30% to 40% (11–13). In our series only
15% of our patients underwent the implantation of a valved
conduit in the 20 years following the transatrial repair.
Patients who had required previous palliation and those
undergoing repair at a later age had higher risk of reoperation
likely because these criteria selected the patients with the
smallest pulmonary arteries and the most narrow outﬂow
tract. Those patients would have needed more extensive
surgery of their outﬂow tract and their smaller pulmonary
Figure 4
Freedom From a Reoperation Involving Implantation
of a Valved Conduit by Age at Fallot Repair
In this historical series, later age at repair was associated with a lower risk of
requiring the implantation of a valved conduit in the right ventricular outﬂow tract
(hazard ratio: 0.70; 95% conﬁdence interval: 0.50 to 0.96; p ¼ 0.03).
Table 1
Parameters Predicting Risk of First Reoperation on the
RVOT or the PAs by Cox Proportional Hazards
Regression Analysis
Factor n HR* p Value 95% CI
Any reoperation
Higher post-op echo gradient 617 1.31 <0.001 1.17–1.45
Age at repair 617 0.67 0.002 0.52–0.86
Patch of PA origin 617 1.59 0.046 1.01–2.51
Prior palliation 617 2.16 0.001 1.39–3.35
Reoperation related to RV dilation
Age at repair 667 0.60 0.019 0.39–0.92
Prior palliation 667 1.99 0.045 1.02–3.92
Monocusp 667 2.66 0.023 1.14–6.19
Transannular patch 667 2.68 0.023 1.14–6.27
Reoperation related to
RVOT obstruction
Higher post-op echo gradient 618 1.41 <0.001 1.27–1.56
Age at repair 618 0.68 0.049 0.47–1.00
Prior palliation 618 2.82 0.001 1.51–5.28
Reoperation related to
PA stenosis
Patch of PA origin 666 4.02 0.003 1.60–10.10
*For echo gradient the hazard ratio (HR) is the multiplicative change in hazard for a 1 SD increase
in echo gradient.
CI ¼ conﬁdence interval; PA ¼ pulmonary artery; post-op ¼ postoperative; RV ¼ right ventricular;
RVOT ¼ right ventricular outﬂow tract.
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afterload precipitating right ventricular dilation.
Similar to others, we attribute the low rate of implantation
of a valved conduit in the RVOT of our patients to the
preservation of the musculature of the outﬂow tract with the
transatrial repair (5–8,14–18). We believe that the closure of
the ventricular septal defect through the tricuspid valve in
the transatrial repair rather than through a right ven-
triculotomy results in the reduction of the length of the
incision of the outﬂow tract. This reduction in the size of the
outﬂow tract incision is at the cost of a low rate of reinter-
vention for RVOT obstruction. The low rate of reoperation
for right ventricular dilation in our series of patients who hadFigure 5
Freedom From a First Reintervention on the
RVOT or the PAs
This diagram displays the freedom from a ﬁrst reintervention on the outﬂow tract.
In the transatrial repair technique, the low rate of implantation of a valved conduit
occurs at the cost of some reintervention for right ventricular (RV) obstruction.
PA ¼ pulmonary artery; RVOT ¼ right ventricular outﬂow tract.a high incidence of incision of the pulmonary annulus tend
to indicate that an aggressive policy of preservation of the
pulmonary annulus may not be useful and could expose
patients to an increased risk of reoperation for outﬂow tract
obstruction.
Our experience was characterized by a traditional approach
of delaying the repair beyond the neonatal period and per-
forming shunting procedure in symptomatic neonates. A
third of our patients ultimately needed a shunting procedure
with a hospital mortality of 1% and an interim mortality of
2%. Hospital mortality after the transatrial repair was 1%.
With this conventional approach, the overall mortality of our
patients from birth to hospital discharge after repair was 2%.
We believe this mortality to be remarkably low for a historical
period spanning over the last 3 decades. While in the recent
years we have decreased the age at which we perform the ﬁnal
repair, we have today opted to maintain our policy to perform
the repair after 4 months of age.
Anecdotal excellent early outcomes have been reported
after neonatal repair, but there are yet no long-term data
indicating the long-term consequences of this policy. Our
data point to a potential higher risk of late reoperation when
patients are operated at an earlier age (19–24). It is possible
that, at a young age, the relief of the RVOT necessitates
more extensive surgery than when performed later and we
think that a strategy of neonatal repair may result in a more
frequent requirement for valve implantation in the RVOT.
Study limitations and strengths. In this retrospective study
spanning over 3 decades, we cannot ascertain that the results
presented are still valid today. However, over this period our
team has maintained the same policy and the same technique.
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for right ventricular dilation and it can be argued that the
indication for reintervention might have varied over the span
of these 3 decades and according to the teams of physicians
following the patients. As we have demonstrated a very small
late mortality and veriﬁed this data in national death regis-
tries, we do not believe that missing data were contributing to
the low rate of reoperation observed. The majority of our
patients were followed by a restricted number of teams
working closely together avoiding large variations in the
indications. It is certain that the indication for reoperation
varied overtime leading to an earlier intervention in the
patients operated in later era. All patients followed today are,
however, subjected to similar indications for reoperation and
we therefore believe that while our estimates of rate of
reoperation may not be valid for the ﬁrst decade after repair,
these estimates should be accurate beyond 20 years. In this
historical series, it is possible that the ﬁnding of earlier
age at repair resulting in less reintervention was a selection
bias resulting from the patients who had the worse
anatomy undergoing an earlier operation. Magnetic reso-
nance imaging measurements of the right ventricular cavities
would be a more consistent approach to analyze the beneﬁts
of our technique and strategy, but these results could not be
collated in this healthy population.
Conclusions
Outcomes after a policy of transatrial repair of tetralogy of
Fallot delayed beyond the neonatal age results in excellent
outcomes in terms of mortality and late requirement for
valvulation of the RVOT.
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